Pharmacological inhibitors of MAPK pathways

Author： English J.M.   Cobb M.H.  

Publisher： Elsevier

E-ISSN： 1873-3735|23|1|40-45

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.1, 2002-01, pp. : 40-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inflammatory Signaling in Cartilage: MAPK and NF-&kgr; B Pathways in Chondrocytes and the Use of Inhibitors for Research into Pathogenesis and Therapy of Osteoarthritis

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 305-313

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological proteasome inhibitors and their therapeutic potential

By Dou Q.P.   Nam S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1263-1272

Informa Healthcare

Access to resources Recommend Favorite

The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 85-97

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of MAPK Signaling Pathways Through Immunophilin-ligand Complex

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 12, 2003-08 ,pp. : 1358-1367

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 2, 2012-02 ,pp. : 120-126

Bentham Science Publishers

Access to resources Recommend Favorite